QUOTED. 4 September 2020. Jared Watkin.
US Medicare has agreed to cover Abbott's FreeStyle Libre 2 continuous glucose monitoring system. See what Jared Watkin, senior VP of Abbott's diabetes care business, said about the move.
"Abbott designed the FreeStyle Libre portfolio for performance, access and affordability to make it broadly available to people with diabetes who need it. By securing reimbursement, Abbott is making sure our latest life-changing technology can get to everyone who needs it, whether they're children, adults or seniors eligible for Medicare."– Jared Watkin, senior VP, diabetes care, Abbott
- Find out more: Abbott's Freestyle Libre 2 Gains Medicare Coverage
Click here for a free trial of Medtech Insight